Effect of the molecular weight of polyethylene glycol on the bioavailability of indomethacin sustained-release suppositories prepared with solid dispersions.
N
N
Ohnishi
Y
Y
Kiyohara
Y
Y
Kita
K
K
Kuroda
T
T
Yokoyama
D000818:Animals; D001682:Biological Availability; D003692:Delayed-Action Preparations; D007213:Indomethacin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008297:Male; D008970:Molecular Weight; D011092:Polyethylene Glycols; D011817:Rabbits; D013488:Suppositories
D003692:Delayed-Action Preparations; D013488:Suppositories; D011092:Polyethylene Glycols; D007213:Indomethacin